Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook

Go back to Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook
(NASDAQ: EOLS) Delayed: 8.78 -0.19 (2.12%)
Previous Close $8.97    52 Week High
Open $8.86    52 Week Low
Day High $9.08    P/E N/A 
Day Low $8.77    EPS
Volume 1,512,317